Subscribe for $2

Subscribe for 2 $

Institutional-grade intelligence for professional investors

LIVE

•Real-time feeds•Global markets•24/7 coverage

Newron Pharmaceuticals SpA Aktie News & Pressemeldungen

Newron Pharmaceuticals SpA Eulerpool News

1/10/2025, 4:35:13 PM

Newron und Myung In Pharm: Partnerschaft zur Entwicklung von Evenamide

1

1

Newron Pharmaceuticals SpA Stock News

Newron Pharmaceuticals SpA is being monitored by journalists and investors worldwide. We gather the latest Newron Pharmaceuticals SpA news here.

May 12 ·
Yahoo
Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS)
March 24 ·
Yahoo
Newron proposes renowned biopharma company founder and entrepreneur Dr. Chris Martin for election as Independent Chairman
January 9 ·
Yahoo
Newron and Myung In Pharm Announce License Agreement for evenamide in South Korea
December 13 ·
Yahoo
Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories
August 8 ·
Yahoo
Aligos Therapeutics Strengthens Board with Two New Independent Directors
June 18 ·
Yahoo
Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City

1

1

Newron Pharmaceuticals SpA Stock Press Releases

Newron Pharmaceuticals SpA regularly publishes news on the company's website that are relevant for investors.

Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan